Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Emerging opportunity in a growing, high-value dermatological market

The following is a transcription of the above video, and The Market Online has edited it for clarity . Kane Biotech Inc. (TSXV:KNE) , a Canadian-based biotech company engaged in the development and commercialization of products that prevent and remove microbial biof...
Ryan Dhillon | 12 days ago |

Buzz on the Bullboards: Bombardier, Baytex and Tilray turn heads

North American stocks have had a strong week. Markets on both sides of the border responded well to the U.S. Federal Reserve’s vote to hold interest rates between 5.25 per cent and 5.50 per cent for a fifth straight meeting. The central bank has kept r...
Jonathon Brown | March 21, 2024 |

Buzz on the Bullboards: The cannabis, tech and oil newsmakers

“The obstacle in the path becomes the path. Never forget, within every obstacle is an opportunity to improve our condition.” That text comes from the 2014 book by businessman Ryan Holiday, “The Obstacle Is the Way: The Timeless Art of Turning T...
Jonathon Brown | March 14, 2024 |

Buzz on the Bullboards: Upbeat U.S. earnings good news for all?

Do rising tides truly lift all ships? We are in the midst of a strong earnings season and U.S. markets have reacted in kind. Strong earnings growth pushed Wall Street indices towards fresh record highs this past week. While activity moved lower earlier on, the belief ...
Jonathon Brown | February 8, 2024 |

Strategic growth, EBITDA success and new leadership: Ciscom's Q3 2023 update

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Today we are talking with Ciscom Corp. (CSE:CISC) , which is focused on technology-driven marketing and advertising and content management organizations. ...
Brieanna McCutcheon | January 29, 2024 |

Buzz on the Bullboards: Tracking Bombardier’s path, Tilray’s growth

This year began on a confusing path for investors as sectors struggle under greater inflation costs and hopes of an imminent interest rate cut fade. A few weeks later in 2024, we are starting to see a clearer picture of where many companies are headed this year. M...
Jonathon Brown | January 18, 2024 |

Clinical research and tools to address mental health

Our next company is Numinus Wellness Inc. (TSX:NUMI) . Numinus is using the power of psychedelic medicine to make great strides in addressing serious mental health issues. It recently announced its fiscal year 2024 results, which showed strong growth in its busines...
Ryan Dhillon | December 14, 2023 |

The copper-gold project ripe for exploration in southern British Columbia

Vancouver-based Sego Resources (TSXV:SGZ) is a copper-gold mining company focused on its 100-per-cent-owned Miner Mountain Project , more than 2,000 hectares in size and located northeast of Princeton, B.C. Joining me in studio to talk about all things Sego, inclu...
Coreena Robertson | December 11, 2023 |

Theralase is raising up to $5.3M to complete bladder cancer study

Theralase Technologies is announcing a brokered financing raise for up to C$5.3 million Proceeds of the financing will be used to further the Phase II Non-Muscle Invasive Bladder Cancer (NMIBC) clinical study Ruvidar is designed to destroy solid core tum...
Coreena Robertson | November 6, 2023 |

Revolutionizing vascular grafting with a durable solution

Our next guest is a multi-technology biomedical company, focused on the development and commercialization of medical technologies. Marizyme Inc. (OTCQB:MRZM) has had its sights set on development of medical technology and products, one of which is DuraGraft. J...
Brieanna McCutcheon | September 27, 2023 |
1 2 3 4 5 6 7 8 9 10 ...